Used in the synthesis of pharmaceutical intermediates, particularly in the development of protease inhibitors and other bioactive molecules. Its bromomethyl group allows for easy alkylation and coupling reactions, making it valuable in constructing complex organic frameworks. Commonly employed in medicinal chemistry for modifying peptide-like structures and enhancing binding affinity in drug candidates. Also utilized in the preparation of covalent inhibitors due to the reactivity of the bromide leaving group, enabling targeted enzyme inhibition.